<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Free Fall Test Protocol - 100-005-RTP-001</title>
    <link rel="stylesheet" href="../../assets/css/summed-medtech-docs.css">
</head>

<body>
    <div class="a4-container">
        <div class="header-section">
            <img src="../../assets/images/Summed logo.png" alt="Summed Medtech 森迈医疗" class="company-logo"
                style="width: 80% !important; max-width: 300px !important; height: auto !important;">
            <div class="document-meta">
                <div><strong>Document No.:</strong> 100-005-RTP-001</div>
                <div><strong>Revision:</strong> 1.0</div>
            </div>
        </div>

        <h1>Free Fall Test Protocol (RTP)</h1>

        <table class="doc-info-table">
            <tr>
                <td width="25%"><strong>Project Name:</strong></td>
                <td colspan="3">Simject-030 Epinephrine Pharma Bridge (Adult) Project</td>
            </tr>
            <tr>
                <td><strong>Project Code:</strong></td>
                <td>SM100-005</td>
                <td><strong>Product Model:</strong></td>
                <td>AISI104</td>
            </tr>
        </table>

        <table class="signature-table">
            <tr>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">Zoey Cai</div>
                        <div class="signature-title">R&D Department (Prepared by)</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Prepared by</div>
                    </div>
                </td>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">YC Zheng</div>
                        <div class="signature-title">Document Control Center</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Reviewed by</div>
                    </div>
                </td>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">Logan Zhao</div>
                        <div class="signature-title">R&D Department</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Reviewed by</div>
                    </div>
                </td>
            </tr>
            <tr>
                <td colspan="2">
                    <div class="signature-block">
                        <div class="signature-name">Kevin Lo</div>
                        <div class="signature-title">R&D Department (Approved by)</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Approved by</div>
                    </div>
                </td>
                <td></td>
            </tr>
        </table>

        <div class="page-break"></div>

        <h2>Table of Contents</h2>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="10%">Section</th>
                    <th width="60%">Title</th>
                    <th width="15%">Page</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>1</td>
                    <td>Table of Contents</td>
                    <td>2</td>
                </tr>
                <tr>
                    <td>2</td>
                    <td>Purpose</td>
                    <td>3</td>
                </tr>
                <tr>
                    <td>3</td>
                    <td>Scope</td>
                    <td>3</td>
                </tr>
                <tr>
                    <td>4</td>
                    <td>Responsibilities</td>
                    <td>3</td>
                </tr>
                <tr>
                    <td>5</td>
                    <td>References</td>
                    <td>3</td>
                </tr>
                <tr>
                    <td>6</td>
                    <td>Definitions</td>
                    <td>3</td>
                </tr>
                <tr>
                    <td>7</td>
                    <td>Sample Information</td>
                    <td>3</td>
                </tr>
                <tr>
                    <td>8</td>
                    <td>Auto-Injector Assembly</td>
                    <td>3</td>
                </tr>
                <tr>
                    <td>9</td>
                    <td>Content</td>
                    <td>4</td>
                </tr>
                <tr>
                    <td>9.1</td>
                    <td>Product Overview</td>
                    <td>4</td>
                </tr>
                <tr>
                    <td>9.2</td>
                    <td>Test Fixtures</td>
                    <td>4</td>
                </tr>
                <tr>
                    <td>9.3</td>
                    <td>Test Equipment</td>
                    <td>4</td>
                </tr>
                <tr>
                    <td>9.4</td>
                    <td>Validation Procedure</td>
                    <td>4</td>
                </tr>
                <tr>
                    <td>9.5</td>
                    <td>Functional Testing</td>
                    <td>5</td>
                </tr>
                <tr>
                    <td>9.6</td>
                    <td>Acceptance Criteria</td>
                    <td>6</td>
                </tr>
                <tr>
                    <td>9.7</td>
                    <td>Validation Report</td>
                    <td>6</td>
                </tr>
                <tr>
                    <td>10</td>
                    <td>Appendix</td>
                    <td>7</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h2>2. Purpose</h2>
        <p>To verify that Simject series - Epinephrine Pharma Bridge (Adult) project products maintain performance
            compliance after free fall testing.</p>

        <h2>3. Scope</h2>
        <p>This protocol applies to free fall testing for Simject series - Epinephrine Pharma Bridge (Adult) project.
        </p>

        <h2>4. Responsibilities</h2>
        <p><strong>4.1.</strong> Analyst: Responsible for drafting this protocol, completing testing according to the
            protocol, and issuing test reports.</p>
        <p><strong>4.2.</strong> R&D Engineer: Responsible for reviewing this protocol.</p>
        <p><strong>4.3.</strong> R&D Director: Responsible for approving this protocol.</p>

        <h2>5. References</h2>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="10%">No.</th>
                    <th width="30%">Standard</th>
                    <th width="60%">Description</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>1</td>
                    <td>YY/T 1768.1-2021</td>
                    <td>Needle-based injection systems for medical use - Requirements and test methods - Part 1:
                        Needle-based injection systems</td>
                </tr>
                <tr>
                    <td>2</td>
                    <td>ISO 11608-1:2022</td>
                    <td>Needle-based injection systems for medical use - Requirements and test methods - Part 1:
                        Needle-based injection systems</td>
                </tr>
            </tbody>
        </table>

        <h2>6. Definitions</h2>
        <ul>
            <li><strong>Container:</strong> Primary packaging containing injection drug (single-chamber or
                multi-chamber)
            </li>
        </ul>

        <div class="page-break"></div>

        <h2>7. Sample Information</h2>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="35%">Sample Name</th>
                    <th width="35%">Sample Model</th>
                    <th width="30%">Batch No.</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Front Component</td>
                    <td>AISI104F0</td>
                    <td></td>
                </tr>
                <tr>
                    <td>Rear Component</td>
                    <td>AISI104R0</td>
                    <td></td>
                </tr>
                <tr>
                    <td>Pre-filled Syringe (PFS)</td>
                    <td></td>
                    <td></td>
                </tr>
            </tbody>
        </table>

        <h2>8. Auto-Injector Assembly</h2>
        <p>Assemble front component, rear component, and PFS according to "000-000-TIS-001 Lisa & Lucy Manual Final
            Assembly
            Fixture Test Instruction V1.0" to obtain finished auto-injectors.</p>

        <div class="page-break"></div>

        <h2>9. Content</h2>

        <h3>9.1. Product Overview</h3>
        <p>Refer to Design Input Requirement (DIR), Document No.: 0df6edb6-13db-4769-89be-2fad4dd4a821.docx</p>

        <h3>9.2. Test Fixtures</h3>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="35%">Fixture No.</th>
                    <th width="65%">Fixture Name</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>JS-JJ-24-022</td>
                    <td>Lisa & Lucy front component and PFS manual final assembly fixture</td>
                </tr>
                <tr>
                    <td>JS-JJ-24-023</td>
                    <td>Lisa & Lucy front component and rear component manual final assembly fixture</td>
                </tr>
                <tr>
                    <td>JS-JJ-25-001</td>
                    <td>Free fall test stand</td>
                </tr>
                <tr>
                    <td>JS-JJ-23-018</td>
                    <td>Free fall test box</td>
                </tr>
                <tr>
                    <td>JS-JJ-24-019</td>
                    <td>Simject series sharps injury protection fixture</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h3>9.3. Test Equipment</h3>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="20%">Equipment No.</th>
                    <th width="30%">Equipment Name</th>
                    <th width="20%">Model</th>
                    <th width="15%">Calibration Valid Until</th>
                    <th width="15%">Calibration Report</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>JS-JC-24-005</td>
                    <td>Simject auto-injector testing equipment</td>
                    <td>Simject</td>
                    <td>2026.05.12</td>
                    <td>EVR-JS-JC-25-001</td>
                </tr>
            </tbody>
        </table>

        <h3>9.4. Validation Procedure</h3>

        <h4>9.4.1. Environmental Conditions</h4>
        <p>Test laboratory temperature and humidity must be controlled within 25 ± 3°C and 55 ± 20% RH range.</p>

        <h4>9.4.2. Free Fall Preconditioning</h4>
        <p><strong>9.4.2.1.</strong> Use auto-injectors assembled per Section 8 for free fall preconditioning. Note that
            before free fall preconditioning, the injector cap should never have been removed, maintaining a tightly
            closed
            state.</p>

        <p><strong>9.4.2.2.</strong> Drop injectors from 1000 mm (1 m) height onto the inner surface of the "free fall
            test
            box" in the following three drop orientations:</p>

        <p><strong>9.4.2.2.1.</strong> <strong>Horizontal orientation:</strong> Drop 10 new injectors in an undisturbed
            manner. If container breakage is easily observed, do not proceed to next test. Determine as test failure.
        </p>

        <p><strong>9.4.2.2.2.</strong> <strong>Vertical orientation (rear cap downward):</strong> Drop 10 new injectors
            in
            an undisturbed manner with rear cap facing downward. If container breakage is easily observed, the system
            shall
            not proceed to next test. Determine as test failure.</p>

        <p><strong>9.4.2.2.3.</strong> <strong>Vertical orientation (cap downward):</strong> Drop 10 new injectors in an
            undisturbed manner with cap facing downward. If container breakage is easily observed, the system shall not
            proceed to next test. Determine as test failure.</p>

        <p><strong>9.4.2.3.</strong> Each test orientation allows up to three obvious container fractures, otherwise
            determine as test failure.</p>

        <p><strong>9.4.2.4.</strong> For each orientation, a total of 10 injectors are dropped, totaling 30 injectors
            across
            all orientations.</p>

        <div class="page-break"></div>

        <h3>9.5. Functional Testing</h3>
        <p>Perform functional testing on the 30 injectors that underwent free fall preconditioning according to
            100-005-TIS-023 (V1.0) functional test method.</p>

        <table class="data-table">
            <thead>
                <tr>
                    <th width="5%">No.</th>
                    <th width="50%">Test Item</th>
                    <th width="45%">Test Method</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>1</td>
                    <td>Dose accuracy</td>
                    <td rowspan="10">100-005-TIS-023 (V1.0)</td>
                </tr>
                <tr>
                    <td>2</td>
                    <td>Needle extension length (during injection)</td>
                </tr>
                <tr>
                    <td>3</td>
                    <td>Cap removal force</td>
                </tr>
                <tr>
                    <td>4</td>
                    <td>Injection activation force (pressing needle shield)</td>
                </tr>
                <tr>
                    <td>5</td>
                    <td>Injection time for 0.3 mL dose</td>
                </tr>
                <tr>
                    <td>6</td>
                    <td>Drug visibility before use</td>
                </tr>
                <tr>
                    <td>7</td>
                    <td>Post-injection needle shield lockout force</td>
                </tr>
                <tr>
                    <td>8</td>
                    <td>Device status indication</td>
                </tr>
                <tr>
                    <td>9</td>
                    <td>Needle shielding</td>
                </tr>
                <tr>
                    <td>10</td>
                    <td>Injection start audible prompt</td>
                </tr>
                <tr>
                    <td>11</td>
                    <td>Sharps injury protection</td>
                    <td></td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h3>9.6. Acceptance Criteria</h3>
        <p><strong>9.6.1.</strong> If complete container breakage is easily observed in any test orientation, determine
            as
            test failure.</p>
        <p><strong>9.6.2.</strong> Each test orientation allows up to three obvious container fractures, otherwise
            determine
            as test failure.</p>
        <p><strong>9.6.3.</strong> Functional test results of auto-injectors after dropping shall meet the standard
            requirements in the following table:</p>

        <table class="data-table">
            <thead>
                <tr>
                    <th width="5%">No.</th>
                    <th width="30%">Test Item</th>
                    <th width="65%">Acceptance Criteria</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>1</td>
                    <td>Dose accuracy</td>
                    <td>0.27 &lt; injection volume &lt; 0.34 mL</td>
                </tr>
                <tr>
                    <td>2</td>
                    <td>Needle extension length (during injection)</td>
                    <td>0.6 in (±0.1 in) / 15.24 mm (±2.54 mm)</td>
                </tr>
                <tr>
                    <td>3</td>
                    <td>Cap removal force</td>
                    <td>5-35 N</td>
                </tr>
                <tr>
                    <td>4</td>
                    <td>Injection activation force (pressing needle shield)</td>
                    <td>5-25 N</td>
                </tr>
                <tr>
                    <td>5</td>
                    <td>Injection time for 0.3 mL dose</td>
                    <td>≤ 2 seconds</td>
                </tr>
                <tr>
                    <td>6</td>
                    <td>Drug visibility before use</td>
                    <td>Window clearly identifiable</td>
                </tr>
                <tr>
                    <td>7</td>
                    <td>Post-injection needle shield lockout force</td>
                    <td>&gt;50 N</td>
                </tr>
                <tr>
                    <td>8</td>
                    <td>Device status indication</td>
                    <td>PFS plunger visible at window after injection</td>
                </tr>
                <tr>
                    <td>9</td>
                    <td>Needle shielding</td>
                    <td>When injector contacts test surface, needle is not visually visible; when injector does not
                        contact
                        test surface, needle does not protrude</td>
                </tr>
                <tr>
                    <td>10</td>
                    <td>Injection start audible prompt</td>
                    <td>Measured at 30 cm from device, loudness ≥ 60 dB</td>
                </tr>
                <tr>
                    <td>11</td>
                    <td>Sharps injury protection</td>
                    <td>ISO 23908-2024 Appendix test method</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h3>9.7. Validation Report</h3>
        <p><strong>9.7.1.</strong> Report shall contain detailed information of used auto-injectors and PFS, including
            model, batch number, quantity, etc.</p>
        <p><strong>9.7.2.</strong> Report shall specify the specific process and detailed data of free fall
            preconditioning
            and functional testing.</p>
        <p><strong>9.7.3.</strong> Report shall include result determination for free fall testing. If testing fails,
            re-testing shall be performed until passed. Each testing process and result shall be recorded and described
            in
            detail in the report.</p>

        <div class="page-break"></div>

        <h2>10. Appendix</h2>

        <!-- Section 10: Appendix - Drop Orientations -->
        <!-- Row 1: Horizontal Orientation (Slightly larger scale per feedback) -->
        <div style="display: flex; justify-content: center; margin: 20px 0 40px 0;">
            <div class="figure-container" style="text-align: center; margin: 0;">
                <img src="../../assets/images/100-005-RTP-10a.png" alt="Horizontal drop orientation"
                    style="width: 350px !important; height: auto !important; border: 1px solid #ccc;">
                <p style="font-size: 9pt; color: #666; margin-top: 8px;">Figure 10-1: Horizontal drop orientation</p>
            </div>
        </div>

        <!-- Row 2: Vertical Orientations -->
        <div style="display: flex; justify-content: center; align-items: flex-start; gap: 60px; margin: 20px 0;">
            <div class="figure-container" style="text-align: center; margin: 0;">
                <img src="../../assets/images/100-005-RTP-10b.png" alt="Vertical cap-down drop orientation"
                    style="height: 300px !important; width: auto !important; border: 1px solid #ccc;">
                <p style="font-size: 9pt; color: #666; margin-top: 8px;">Figure 10-2: Vertical cap-down orientation</p>
            </div>
            <div class="figure-container" style="text-align: center; margin: 0;">
                <img src="../../assets/images/100-005-RTP-10c.png" alt="Vertical rear cap-down drop orientation"
                    style="height: 300px !important; width: auto !important; border: 1px solid #ccc;">
                <p style="font-size: 9pt; color: #666; margin-top: 8px;">Figure 10-3: Vertical rear cap-down orientation
                </p>
            </div>
        </div>

        <div class="footer">
            <p>Summed Medtech 森迈医疗 | Document No.: 100-005-RTP-001 | Revision: 1.0</p>
        </div>
    </div>
</body>

</html>